Tuesday, December 23, 2025
Today's Print

Tag: Novartis

Press institute, Novartis hold health workshop

The Philippine Press Institute (PPI) together with Novartis held a hybrid seminar-workshop for journalists entitled “Anatomy of a Silent Killer: Unblock your Heart, Unfriend...

Novartis new innovative therapy lowers bad cholesterol helping to prevent heart attack

 ●    When high levels of low-density lipoprotein cholesterol (LDL-C or bad cholesterol) are untreated for a long time, they lead to the accumulation of fatty...

Novartis innovative therapy can help high-risk patients control bad cholesterol

· High levels of low-density lipoprotein cholesterol (LDL-C or bad cholesterol) can lead to an accumulation of...

Novartis innovative therapy to lower bad cholesterol can help high-risk patients turn second chances to lifelong victories

"Jessica" (not her real name) was at the peak of her career as an accomplished executive in a prominent corporation based in Makati. However,...

Novartis session in Philippine National Cancer Summit 2024 highlights Key Role of Patient Navigators in Enhancing Breast Cancer Survivorship

●       Patient navigators took center stage at the plenary session supported by Novartis Healthcare Philippines during the Philippine National Cancer Summit 2024. Entitled “Beyond the...

PH Press Institute, Novartis, ICanServe team up to enhance breast cancer info

Recognizing the key role of media in health literacy promotion, Novartis Healthcare Philippines, Philippine Press Institute (PPI), and ICanServe Foundation have signed a memorandum...

Novartis, Ask Your Derm PH raise awareness on pediatric psoriasis

Reveals effective treatments to help children manage symptoms, enjoy life Psoriasis causes a significant physical, emotional, and psychological burden on children and adolescents. Fortunately, effective...

Indonesia, Philippines and Vietnam: Building on lessons learned to enhance eyecare services beyond COVID-19

● Collaboration to Preserve Sight partners from Indonesia, Vietnam and the Philippines gathered anew in a virtual forum titled “How can 2030 In Sight...

Novartis, partners raise awareness on AxSpA, a debilitating spine and joint disease

●            Axial Spondyloarthritis (AxSpA) is a debilitating disease that significantly impacts quality of life. ●            Advances in early diagnosis and treatment of non-radiographic (nr-AxSpA) are...

Novartis backs hydroxychloroquine trial in COVID-19 fight

Zurich - Swiss pharmaceutical giant Novartis said Monday it would sponsor a clinical trial in the US using hydroxychloroquine to treat patients hospitalised with...

Pharma firm cuts prices of hypertension, epilepsy meds in PH

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; font: 10.0px 'Times New Roman'} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; text-indent: 9.0px; font: 10.0px...

$100 million for malaria drug reasearch

ZURICH -­ Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for...
- Advertisement -spot_img
- Advertisement -spot_img